Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1Genitourinary 1

Conditions

Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Recurrence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Obesity 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Glucocorticoids × Clear all
NCT01576588 2019-12-27

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Vilnius University

Phase 2 Completed
25 enrolled 9 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00805207 2018-08-01

SCOR

Washington University School of Medicine

Phase NA Completed
61 enrolled 17 charts
Other

Obesity, Polycystic Ovary Syndrome, Sleep Apnea Syndromes, Sleep Apnea, Obstructive

NCT00474383 2014-05-12

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Cougar Biotechnology, Inc.

Phase 2 Completed
47 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡